Profound Medical And 2 Other Canadian AI Healthcare Stocks To Watch

Rising global bond yields are forcing investors to rethink where long term growth might come from as higher borrowing costs pressure many traditional sectors. Canadian artificial intelligence healthcare companies sit at the crossroads of technology and medicine, targeting problems that matter regardless of the interest rate cycle. This article highlights three stocks from a focused AI in healthcare screener that could help you research this theme more efficiently.

These three stocks are just a starting sample for the theme, and the full screen surfaced 6 more AI healthcare companies with equally compelling narratives that are not covered below. To identify and analyze potential high-conviction ideas across this space, head straight to the Transformative Artificial intelligence (AI) Healthcare Stocks screener.

Profound Medical (TSX:PRN)

Overview: Profound Medical develops AI-powered, MRI-guided robotic systems like TULSA-PRO and Sonalleve for incision-free, image-guided ablation of diseased tissue.

Operations: Profound Medical generates about $19 million from its Medical Technology segment, with roughly $12 million from the USA and $6 million from Canada.

Market Cap: CA$296 million

Profound Medical plugs directly into the AI healthcare theme through TULSA-PRO and Sonalleve, which use MRI data, algorithms and robotics to guide incision-free ablation in real time. Recent TULSA-PRO software upgrades and CAPTAIN trial data aim to standardize outcomes and support quality-of-life benefits. However, one unresolved factor could heavily influence how that AI-guided precision shows up in future margins and demand.

To see how that unresolved factor relates to risks and potential upside, read the 1 key reward and 1 important warning sign

Healwell AI (TSX:AIDX)

Overview: Healwell AI builds healthcare AI engines and clinical decision support tools that help clinicians detect rare and chronic diseases and personalize treatment.

Operations: Healwell AI generates about CA$119 million from Healthcare Software and CA$10 million from AI and Data Sciences, primarily in Australia and New Zealand.

Market Cap: CA$235 million

Healwell AI taps directly into the Transformative AI Healthcare Stocks theme by turning messy clinical data into usable insights for front line teams. A key area of focus for investors is how that model scales as more health systems embed its tools into everyday workflows.

"The vast and growing pool of digitized healthcare data, strengthened by ongoing adoption of telemedicine and electronic health records worldwide, will influence the training and effectiveness of Healwell's AI models, potentially enabling the launch of next-generation clinical decision tools, changes in pricing, and expanded SaaS revenue streams."

How might Healwell AI’s margins and pricing dynamics change if clinician trust and large enterprise deployments increase toward the scale its model is built for?

If that trust gap closes at scale, the full narrative for Healwell AI shows how Healwell AI could accelerate adoption, reshape contracts and surface risks that the headline story barely hints at.

Perimeter Medical Imaging AI (TSXV:PINK)

Overview: Perimeter Medical Imaging AI develops Claire OCT with ImgAssist AI and S-Series OCT systems that give surgeons real-time tissue margin imaging during breast cancer operations.

Operations: Perimeter Medical Imaging AI generates about $2 million from Medical Imaging Systems, with all reported revenue currently coming from Canada.

Market Cap: CA$43 million

Perimeter Medical Imaging AI brings AI directly into the operating room through Claire OCT with ImgAssist, which supports real-time breast cancer margin assessment and is intended to reduce repeat surgeries by improving what surgeons can see at the edge of removed tissue. Revenue remains small and losses continue, so the key factor is how hospital adoption affects pricing and demand over time.

That adoption curve is the real swing factor, so check the 2 key rewards and 3 important warning signs (1 is major!) to see how Perimeter Medical Imaging AI’s hospital traction could decouple risk from upside.

Seeking Fresh Alternatives Beyond AI?

Fresh themes move fast, and the best breakout ideas rarely stay under the radar for long. Scan these curated lists before momentum is fully established, then act based on your own research and judgment.

• Spot cash generative outliers before they hit everyone’s screens by running the 7 high quality undervalued stocks and focus on quality businesses while the pricing still looks reasonable.
• Target real earnings instead of hype by scanning the 37 profitable AI stocks that aren't just burning cash and focus on AI players already turning revenue into bottom line results.
• Track structural demand in power and grid upgrades by checking the 39 power grid technology and infrastructure stocks and follow companies positioned around critical infrastructure investment while it still feels early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com